Gastric inhibitory polypeptide (GIP) potently stimulates insulin secretion from pancreatic islets in the presence of
glucose as an
incretin. Because the insulinotropic effect of GIP is reduced in
NIDDM, it should be clarified whether defects in the
GIP receptor gene contribute to the impaired insulin secretion in
NIDDM. Using genomic
DNA samples from Japanese
NIDDM and non-
NIDDM subjects, we have investigated the entire coding region of the
GIP receptor gene by polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP). We have identified two missense mutations, Gly198-->Cys (Gly198Cys) in exon 7 and Glu354-->Gln (Glu354Gln) in exon 12. Investigation of the function of
GIP receptor with either of these mutations reveals a half-maximal stimulation value of GIP-induced cAMP response in Chinese hamster ovary cells expressing the
GIP receptor with Gly198Cys of 6.3 +/- 1.2 x 10(-10) mol/l (n = 3), which was considerably higher than that of the normal
GIP receptor, 9.4 +/- 3.8 x 10(-12) mol/l GIP (n = 3), whereas that of the
GIP receptor with Glu354Gln was not significantly different from that of the normal
GIP receptor. To assess the possible role of the
GIP receptor gene in
genetic susceptibility to
NIDDM, we have examined the allelic frequencies of Gly198Cys and Glu354Gln in
NIDDM and control subjects. Association studies show no relationship between
NIDDM and either of the two mutations.